Credo Life Science
Posted on 27th January 2022

Posted on 27th January 2022

Tablet manufacturing can be slow, costly and complex when every batch must be wet granulated, dried and milled before compression. Direct compression, in which the powder blend is compressed straight into tablets, offers a shorter route, but not every active ingredient flows or compresses well on its own. DC granules, short for direct compression granules, bridge this gap. This guide explains what DC granules are, why formulators use them and how to choose a DC granules supplier.
DC granules are pre-processed forms of active ingredients, or in some cases excipients, that have been granulated or otherwise engineered to have good flow and compressibility. They allow tablets to be made by direct compression, without the need for a separate wet or dry granulation step at the tablet manufacturer’s facility.
Simplified Manufacturing: Eliminating granulation, drying and milling steps shortens the process, reduces equipment needs and saves labour and time.
Better Flow and Compressibility: Granules flow more smoothly than fine powders, enabling consistent die filling, accurate tablet weight and fewer problems such as capping or lamination.
Content Uniformity: Well-designed DC granules resist segregation, supporting uniform drug distribution across the batch.
Lower Dust and Handling Risks: Granules generate less dust than fine powders, which improves handling and operator safety.
Efficient Use of Energy and Time: Fewer unit operations mean lower energy consumption, less cleaning and faster batch turnaround.
DC grades are commonly produced for APIs that are widely used in high doses and are difficult to compress, such as some analgesics, antipyretics and antidiabetic agents. Formulators of tablets with high drug loading often find them particularly valuable, since there is little room for excipients that would otherwise improve flow and compression.
Key quality parameters for evaluating direct compression granules:
Microbial and residual solvent limits must also strictly adhere to pharmacopoeial thresholds.
Technical Capability: The supplier should have well-established granulation technology and process control to deliver reproducible granule properties. Ask about the binders and excipients used, since these influence compatibility with your formula.
Documentation and Compliance: Request specifications, certificates of analysis, regulatory documents, change control policy and information on the quality system. A reliable supplier will be open about excipients and manufacturing controls.
Consistency Between Batches: Variability in particle size or moisture between batches can disrupt tablet compression. Ask how the supplier controls and monitors these parameters.
Pilot-scale evaluations help you confirm tablet quality before committing to commercial supply. A supplier that supports trials and troubleshooting adds value.
Look for dependable lead times, suitable packaging that protects against moisture and clear labelling and traceability.
Points to monitor during blending and compression:
Store DC granules in tightly closed containers in a cool, dry place, away from moisture and strong odours. Use the stock according to a first-in, first-out system and reseal opened containers carefully, because granules can absorb humidity and lose their flow properties.
DC Granules Versus Wet Granulation: Wet granulation takes time and involves mixing, wetting, drying and milling, but can be suitable for products with poor compressibility. DC granules transfer much of this complexity to the supplier, so that the tablet maker focuses on blending and compression. For heat- or moisture-sensitive APIs, avoiding wet processing can also help maintain stability.
Cost Considerations: DC granules may cost more per kilogram than the bulk API, but the savings in time, equipment and labour often outweigh the difference. Evaluate the total cost of manufacture, not only the raw material price.
Credo Life Sciences focuses on pharmaceutical pellets and granules for formulation companies that need consistent quality, dependable supply and clear technical communication. We understand that a multiparticulate ingredient is only as good as its reproducibility from batch to batch, so our approach centres on controlled processes, thorough documentation and responsive support for your development and commercial needs. We work as a long-term partner to our customers, not just a vendor.
DC granules offer tablet manufacturers a faster, simpler and more reliable route to quality tablets. The benefits depend on consistent granule quality and a supplier who shares technical knowledge. If you are looking for a DC granules supplier, contact us to discuss your requirements.
Partner with Credo Life Sciences for your pellet and granule requirements. Contact our team to discuss specifications and quotations.